Processa Pharmaceuticals, Inc. (PCSA) Financials

PCSA Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 8.1 million 914847
2023-06-30 10.1 million 930741
2023-03-31 12.4 million 2.3 million
2022-12-31 8.6 million 1.1 million

PCSA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -1.8 million 142894
2023-06-30 -2.1 million 319123
2023-03-31 -2.1 million 341504
2022-12-31 -2.5 million 2.8 million

PCSA Net Income

No data available :(

PCSA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 6.9 million - 171521
2023-06-30 8.7 million - 191217
2023-03-31 10.7 million - 210524
2022-12-31 6.5 million - 229450

PCSA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 27.0 million
2023-06-30 26.9 million
2023-03-31 22.8 million
2022-12-31 15.3 million

PCSA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 2776 1.2 million 1.0 million -
2023-06-30 - 1.7 million 1.0 million -
2023-03-31 - 1.6 million 2.5 million -
2022-12-31 - 3.2 million 2.6 million -

PCSA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 2.2 million
2023-06-30 - 2.7 million
2023-03-31 - 4.1 million
2022-12-31 - 216515

PCSA

Price: $2.17

52 week price:
1.45
18.00

Earnings Per Share: -22.80 USD

P/E Ratio: -0.11

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 125600

Market Capitalization: 3.1 million

Links: